These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9129992)

  • 21. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells.
    Eigler A; Sinha B; Endres S
    Biochem Biophys Res Commun; 1993 Oct; 196(1):494-501. PubMed ID: 8216333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrolyzed metabolites of thalidomide: synthesis and TNF-alpha production-inhibitory activity.
    Nakamura T; Noguchi T; Miyachi H; Hashimoto Y
    Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):651-4. PubMed ID: 17409565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shedding of soluble receptor for tumor necrosis factor alpha induced by M. leprae or LPS from human mononuclear cells.
    Santos DO; Lorré K; de Boer M; Van Heuverswyn H
    Nihon Hansenbyo Gakkai Zasshi; 1999 Nov; 68(3):185-93. PubMed ID: 10659614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells.
    Hâncu N; Netea MG; Baciu I
    Rom J Physiol; 1998; 35(3-4):325-30. PubMed ID: 11061332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis.
    Tramontana JM; Utaipat U; Molloy A; Akarasewi P; Burroughs M; Makonkawkeyoon S; Johnson B; Klausner JD; Rom W; Kaplan G
    Mol Med; 1995 May; 1(4):384-97. PubMed ID: 8521296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human interleukin 6 and tumor necrosis factor alpha production studied at a single-cell level.
    Andersson U; Matsuda T
    Eur J Immunol; 1989 Jun; 19(6):1157-60. PubMed ID: 2526742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.
    Feist W; Ulmer AJ; Wang MH; Musehold J; Schlüter C; Gerdes J; Herzbeck H; Brade H; Kusumoto S; Diamantstein T
    FEMS Microbiol Immunol; 1992 Jan; 4(2):73-89. PubMed ID: 1547025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative.
    Shannon EJ; Sandoval F
    Immunopharmacology; 1995 Nov; 31(1):109-16. PubMed ID: 8655287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
    Moreira AL; Sampaio EP; Zmuidzinas A; Frindt P; Smith KA; Kaplan G
    J Exp Med; 1993 Jun; 177(6):1675-80. PubMed ID: 8496685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation.
    Endres S; Cannon JG; Ghorbani R; Dempsey RA; Sisson SD; Lonnemann G; Van der Meer JW; Wolff SM; Dinarello CA
    Eur J Immunol; 1989 Dec; 19(12):2327-33. PubMed ID: 2514105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor-alpha and its receptors.
    Chheda S; Palkowetz KH; Garofalo R; Rassin DK; Goldman AS
    Pediatr Res; 1996 Sep; 40(3):475-83. PubMed ID: 8865287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner.
    Payvandi F; Wu L; Haley M; Schafer PH; Zhang LH; Chen RS; Muller GW; Stirling DI
    Cell Immunol; 2004 Aug; 230(2):81-8. PubMed ID: 15598423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
    Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
    J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.
    Corral LG; Muller GW; Moreira AL; Chen Y; Wu M; Stirling D; Kaplan G
    Mol Med; 1996 Jul; 2(4):506-15. PubMed ID: 8827720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isosteric analogs of lenalidomide and pomalidomide: synthesis and biological activity.
    Ruchelman AL; Man HW; Zhang W; Chen R; Capone L; Kang J; Parton A; Corral L; Schafer PH; Babusis D; Moghaddam MF; Tang Y; Shirley MA; Muller GW
    Bioorg Med Chem Lett; 2013 Jan; 23(1):360-5. PubMed ID: 23168019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulation by thalidomide: systematic review of the literature and of unpublished observations.
    Zwingenberger K; Wnendt S
    J Inflamm; 1995-1996; 46(4):177-211. PubMed ID: 8878794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct influence of mild hypothermia on cytokine expression and release in cultures of human peripheral blood mononuclear cells.
    Russwurm S; Stonāns I; Schwerter K; Stonāne E; Meissner W; Reinhart K
    J Interferon Cytokine Res; 2002 Feb; 22(2):215-21. PubMed ID: 11911804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine production in transient hypogammaglobulinemia and isolated IgA deficiency.
    Kowalczyk D; Mytar B; Zembala M
    J Allergy Clin Immunol; 1997 Oct; 100(4):556-62. PubMed ID: 9338552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.
    Aleman M; De La Barrera S; Fink S; Finiasz M; Farina MH; Pizzariello G; Sasiain MD
    Scand J Immunol; 2000 Mar; 51(3):262-70. PubMed ID: 10736095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.